Worldwide demand for commercial accelerator-based technology is being driven by major societal challenges. In the healthcare sector, there is strong demand for radioisotopes to support life science research and to enable diagnostic and therapeutic applications.
The recent commissioning of AAPS’ Isotope Separator Test Facility signaled a major step towards developing a new method for producing high value isotopes for use in medical imaging and cancer therapies. READ MORE>
Collaborating to Secure Canada’s Supply of Isotopes Crucial for Medical Imaging
The recent technetium-99m (Tc-99m) supply crisis has driven urgent efforts towards assessing the viability of using the electromagnetic isotope separation approach to help solve long-term supply issues.
